Glyncoch Pharmacy Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 08943062

Glyncoch Pharmacy Limited

Filleted Unaudited Financial Statements

For the year ended

31 October 2025

Glyncoch Pharmacy Limited

Financial Statements

Year ended 31 October 2025

Contents	Page

Officers and professional advisers	1

Accountant's report to the board of directors on the preparation of the unaudited statutory financial statements of Glyncoch Pharmacy Limited	2

Statement of financial position	3

Notes to the financial statements	5

Glyncoch Pharmacy Limited

Officers and Professional Advisers

The board of directors	Mr L O Smart
	Mrs P H Dodhia Smart

Registered office	65 Porcher Avenue
	Glyncoch
	Pontypridd
	CF37 3DD

Accountants	Clay Shaw Thomas Ltd

	2 Oldfield Road
	Bocam Park
	Bridgend
	CF35 5LJ

Bankers	Lloyds Bank Plc
	Market Square
	Pontypridd
	Rhondda Cynnon Taff
	CF37 2TF

Glyncoch Pharmacy Limited

Accountant's Report to the Board of Directors on the Preparation of the Unaudited Statutory Financial Statements of Glyncoch Pharmacy Limited

Year ended 31 October 2025

As described on the statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 31 October 2025, which comprise the statement of financial position and the related notes. You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.

Clay Shaw Thomas Ltd

2 Oldfield Road Bocam Park Bridgend CF35 5LJ

22 July 2026

Glyncoch Pharmacy Limited

Statement of Financial Position

31 October 2025

	2025		2024
Note	£	£	£

Fixed assets

Tangible assets	6		21,214	27,264

Current assets

Stocks		48,340	40,862
Debtors	7	172,246	219,882
Cash at bank and in hand		179,039	54,888
		---------	---------
		399,625	315,632

Creditors: amounts falling due within one year	8	197,476		246,595
		---------		---------
Net current assets			202,149	69,037
			---------	--------
Total assets less current liabilities			223,363	96,301

Provisions

Taxation including deferred tax	3,812	5,230
	---------	--------
Net assets	219,551	91,071
	---------	--------

Capital and reserves

Called up share capital	2	2
Profit and loss account	219,549	91,069
	---------	--------
Shareholders funds	219,551	91,071
	---------	--------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Glyncoch Pharmacy Limited

Statement of Financial Position (continued)

31 October 2025

These financial statements were approved by the board of directors and authorised for issue on 22 July 2026 , and are signed on behalf of the board by:

Mrs P H Dodhia Smart

Director

Company registration number: 08943062

Glyncoch Pharmacy Limited

Notes to the Financial Statements

Year ended 31 October 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 65 Porcher Avenue, Glyncoch, Pontypridd, CF37 3DD.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.

Going concern

The directors have assessed whether there are any material uncertainties that may cast significant doubt about the company's ability to continue to adopt the going concern basis of accounting for a period of at least twelve months from the date when the financial statements are authorised for issue. In assessing whether the going concern assumption is appropriate, the directors have taken in to account all available information about the future, and conclude that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer, usually on despatch of the goods, the amount of revenue can be measured reliably, it is probable that the associated economic benefits will flow to the entity, and the costs incurred or to be incurred in respect of the transactions can be measured reliably. Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that it is probable the expenses recognised will be recovered.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Goodwill

Goodwill arises on business acquisitions and represents the excess of the cost of the acquisition over the company's interest in the net amount of the identifiable assets, liabilities and contingent liabilities of the acquired business. Goodwill is measured at cost less accumulated amortisation and accumulated impairment losses. It is amortised on a straight-line basis over its useful life. Where a reliable estimate of the useful life of goodwill or intangible assets cannot be made, the life is presumed not to exceed ten years.

Amortisation

Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:

	Goodwill	-	10% straight line

If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Fixtures and fittings	-	20% straight line
Motor vehicles	-	25% reducing balance
Equipment	-	33% straight line

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Provisions

Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.

Financial instruments

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities. Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet. Finance costs and gains or losses relating to financial liabilities are included in the profit and loss account. Finance costs are calculated so as to produce a constant rate of return on the outstanding liability. Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 6 (2024: 7 ).

5. Intangible assets

	Goodwill
	£
Cost
At 1 November 2024 and 31 October 2025	515,000
	---------
Amortisation
At 1 November 2024 and 31 October 2025	515,000
	---------
Carrying amount
At 31 October 2025	–
	---------
At 31 October 2024	–
	---------

6. Tangible assets

	Fixtures and fittings	Motor vehicles	Computer equipment	Total
	£	£	£	£
Cost
At 1 November 2024	38,642	8,000	3,797	50,439
Additions	–	–	3,421	3,421
	--------	-------	-------	--------
At 31 October 2025	38,642	8,000	7,218	53,860
	--------	-------	-------	--------
Depreciation
At 1 November 2024	14,327	5,189	3,659	23,175
Charge for the year	8,218	703	550	9,471
	--------	-------	-------	--------
At 31 October 2025	22,545	5,892	4,209	32,646
	--------	-------	-------	--------
Carrying amount
At 31 October 2025	16,097	2,108	3,009	21,214
	--------	-------	-------	--------
At 31 October 2024	24,315	2,811	138	27,264
	--------	-------	-------	--------

7. Debtors

	2025	2024
	£	£
Trade debtors	99,473	178,526
Amounts owed by group	58,164	–
Other debtors	14,609	41,356
	---------	---------
	172,246	219,882
	---------	---------

8. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	122,622	118,520
Amounts owed to group	–	114,397
Social security and other taxes	37,749	10,254
Other creditors	37,105	3,424
	---------	---------
	197,476	246,595
	---------	---------

9. Directors' advances, credits and guarantees

Transactions with the directors during the year were as follows:

		2025
		£
	Balance owed to company at 1 November 2024	(26,463)
	Introduced	60,000
		--------
	Balance owed from company at 31 October 2025	33,537
		--------

There are no set terms of repayment on this loan and no interest has been charged.

10. Related party transactions

The company has taken exemption under section 33 of FRS102 not to disclose related party transactions with wholly owned members of a group. The company has also taken exemption under the small companies regime from disclosing related party transactions that are considered immaterial or conducted under normal market conditions.